| Peer-Reviewed

Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report

Received: 15 December 2014     Accepted: 22 December 2014     Published: 27 December 2014
Views:       Downloads:
Abstract

Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder in children that shows comorbidity with several psychopathology included stuttering. The prefrontal cortex is the area of brain that sends and receives projections from virtually all cortical sensory systems, motor systems, and many subcortical structures. It has been shown that psychostimulant medication increases activation of the inferior prefrontal cortex and the basal ganglia. Both functional neuroimaging and neuropsychological studies show that psychostimulant medication improves executive functions. Verbal fluency is also considered as one of the executive functions. In this article, we report osmotic-controlled release oral delivery system (OROS) methylphenidate treatment effectiveness of stuttering that combined with ADHD.

Published in American Journal of Psychiatry and Neuroscience (Volume 2, Issue 6)
DOI 10.11648/j.ajpn.20140206.16
Page(s) 115-117
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2014. Published by Science Publishing Group

Keywords

ADHD, Stuttering, Psychostimulants, Treatment

References
[1] Kotte A, Faraone SV, Biederman J. Association of genetic risk severity with ADHD clinical characteristics. Am J Med Genet B Neuropsychiatr Genet. 2013;7:718-33.
[2] Generali JA, Cada DJ. Risperidone: Stuttering. Hosp Pharm. 2014; 49:242-3.
[3] Devroey D, Beerens G,Van De Vijver E. Methylphenidate as a treatment for stuttering: a case report. Eur Rev Med Pharmacol Sci. 2012;16: 66-69
[4] Shaygannejad V, Khatoonabadi SA , Shafiei B, Ghasemi M, Fatehi F, Meamar R et al. Olanzapine Versus Haloperidol: Which Can Control Stuttering Better? Int J Prev Med. May 2013; 4: 270–273.
[5] Donaher J, Richels C. Traits of attention deficit/hyperactivity disorder in school-age children who stutter. J Fluency Disord. 2012;37:242-52.
[6] Arnsten AF, Wang MJ, Paspalas CD. Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses. Neuron. 2012; 76:223-39.
[7] Arnsten AF. Catecholamine influences on dorsolateral prefrontal cortical networks. Biol Psychiatry. 2011;15;69:89-99.
[8] Arnsten AF, Pliszka SR. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacol Biochem Behav. 2011;99:211-6.
Cite This Article
  • APA Style

    Sahin Bodur, Yetis Isildar, Halil Kara, Murat Sabanci. (2014). Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report. American Journal of Psychiatry and Neuroscience, 2(6), 115-117. https://doi.org/10.11648/j.ajpn.20140206.16

    Copy | Download

    ACS Style

    Sahin Bodur; Yetis Isildar; Halil Kara; Murat Sabanci. Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report. Am. J. Psychiatry Neurosci. 2014, 2(6), 115-117. doi: 10.11648/j.ajpn.20140206.16

    Copy | Download

    AMA Style

    Sahin Bodur, Yetis Isildar, Halil Kara, Murat Sabanci. Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report. Am J Psychiatry Neurosci. 2014;2(6):115-117. doi: 10.11648/j.ajpn.20140206.16

    Copy | Download

  • @article{10.11648/j.ajpn.20140206.16,
      author = {Sahin Bodur and Yetis Isildar and Halil Kara and Murat Sabanci},
      title = {Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report},
      journal = {American Journal of Psychiatry and Neuroscience},
      volume = {2},
      number = {6},
      pages = {115-117},
      doi = {10.11648/j.ajpn.20140206.16},
      url = {https://doi.org/10.11648/j.ajpn.20140206.16},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajpn.20140206.16},
      abstract = {Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder in children that shows comorbidity with several psychopathology included stuttering. The prefrontal cortex is the area of brain that sends and receives projections from virtually all cortical sensory systems, motor systems, and many subcortical structures. It has been shown that psychostimulant medication increases activation of the inferior prefrontal cortex and the basal ganglia. Both functional neuroimaging and neuropsychological studies show that psychostimulant medication improves executive functions. Verbal fluency is also considered as one of the executive functions. In this article, we report osmotic-controlled release oral delivery system (OROS) methylphenidate treatment effectiveness of stuttering that combined with ADHD.},
     year = {2014}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report
    AU  - Sahin Bodur
    AU  - Yetis Isildar
    AU  - Halil Kara
    AU  - Murat Sabanci
    Y1  - 2014/12/27
    PY  - 2014
    N1  - https://doi.org/10.11648/j.ajpn.20140206.16
    DO  - 10.11648/j.ajpn.20140206.16
    T2  - American Journal of Psychiatry and Neuroscience
    JF  - American Journal of Psychiatry and Neuroscience
    JO  - American Journal of Psychiatry and Neuroscience
    SP  - 115
    EP  - 117
    PB  - Science Publishing Group
    SN  - 2330-426X
    UR  - https://doi.org/10.11648/j.ajpn.20140206.16
    AB  - Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder in children that shows comorbidity with several psychopathology included stuttering. The prefrontal cortex is the area of brain that sends and receives projections from virtually all cortical sensory systems, motor systems, and many subcortical structures. It has been shown that psychostimulant medication increases activation of the inferior prefrontal cortex and the basal ganglia. Both functional neuroimaging and neuropsychological studies show that psychostimulant medication improves executive functions. Verbal fluency is also considered as one of the executive functions. In this article, we report osmotic-controlled release oral delivery system (OROS) methylphenidate treatment effectiveness of stuttering that combined with ADHD.
    VL  - 2
    IS  - 6
    ER  - 

    Copy | Download

Author Information
  • Child and Adolescent Psychiatry, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey

  • Child and Adolescent Psychiatry, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey

  • Child and Adolescent Psychiatry, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey

  • Child and Adolescent Psychiatry, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey

  • Sections